|
US4599231A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
AU579148B2
(en)
|
1984-03-09 |
1988-11-17 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis b virus vaccine including both t cell and b cell determinants
|
|
US4886782A
(en)
|
1987-02-26 |
1989-12-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
Malarial immunogen
|
|
US5433948A
(en)
|
1990-02-13 |
1995-07-18 |
Thomas; Wayne R. |
Cloning and sequencing of allergens of dermatophagoides (house dust mite)
|
|
JPH06501260A
(ja)
|
1990-09-27 |
1994-02-10 |
シンテロ ヴァクシーン ディベロップメント ケービー |
ヒト免疫不全ウィルスに対する中和抗体の誘発とワクチン接種に用いられるペプチド
|
|
HU220462B1
(hu)
|
1991-10-16 |
2002-02-28 |
Immulogic Pharmaceutical Corp. |
A Dermatophagoides nemzetség allergénjéből származó peptidek, ezeket tartalmazó gyógyszerkészítmények és eljárás házi poratka-érzékenység kimutatására
|
|
US7252829B1
(en)
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
US5589582A
(en)
|
1992-10-27 |
1996-12-31 |
Biotransplant, Inc. |
Polynucleotides en coding porcine cytokines
|
|
US5633234A
(en)
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
|
US5824315A
(en)
|
1993-10-25 |
1998-10-20 |
Anergen, Inc. |
Binding affinity of antigenic peptides for MHC molecules
|
|
US8791237B2
(en)
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
AU1124499A
(en)
|
1997-10-28 |
1999-05-17 |
Maxygen, Inc. |
Human papillomavirus vectors
|
|
NO315238B1
(no)
|
1998-05-08 |
2003-08-04 |
Gemvax As |
Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
|
|
AR020102A1
(es)
|
1998-07-30 |
2002-04-10 |
Ucb Sa |
Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
|
|
US20030152581A1
(en)
|
1998-07-30 |
2003-08-14 |
Jean-Marie Saint-Remy |
Compound and method for the prevention and/or the treatment of allergy
|
|
US6656471B1
(en)
|
1998-11-17 |
2003-12-02 |
Board Of Regents, The University Of Texas System |
HIV-specific T-cell induction
|
|
GB0006437D0
(en)
|
2000-03-17 |
2000-05-10 |
Leuven Res & Dev Vzw |
Compounds for the modulation of allergen sensitivity by antigens sharing T cell epitopes with allergens
|
|
US7226770B2
(en)
*
|
2000-04-28 |
2007-06-05 |
Novozymes A/S |
Lipolytic enzyme variant
|
|
US20030104570A1
(en)
|
2000-06-26 |
2003-06-05 |
Cabezon Silva Teresa Elisa Virginia |
Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
|
|
US7049413B2
(en)
|
2001-05-18 |
2006-05-23 |
Ludwig Institute For Cancer Research |
MAGE-A3 peptides presented by HLA class II molecules
|
|
EP1409650B1
(en)
|
2001-05-30 |
2006-04-12 |
Fondazione Telethon |
Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof
|
|
AU2002333865B2
(en)
|
2001-10-03 |
2006-02-23 |
Unilever Plc |
Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
|
|
AU2003215395A1
(en)
|
2002-02-21 |
2003-09-09 |
Apovia, Inc. |
STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS
|
|
US20100183652A1
(en)
|
2002-02-21 |
2010-07-22 |
Mark Page |
STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS
|
|
TW200413406A
(en)
|
2002-08-26 |
2004-08-01 |
Kirin Brewery |
Peptides and drugs containing the same
|
|
EP2267023B1
(en)
|
2002-09-12 |
2015-02-11 |
Oncotherapy Science, Inc. |
KDR peptides and vaccines comprising the same
|
|
JP2004147649A
(ja)
|
2002-10-11 |
2004-05-27 |
Kumamoto Technology & Industry Foundation |
頭頚部癌の抗原
|
|
WO2005012502A2
(en)
|
2003-03-28 |
2005-02-10 |
Idm Pharma, Inc. |
Methods of identifying optimal variants of peptide epitopes
|
|
US7651855B2
(en)
|
2003-04-17 |
2010-01-26 |
The Trustees Of The University Of Pennsylvania |
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
|
|
GB0324265D0
(en)
|
2003-10-16 |
2003-11-19 |
Medical Res Council |
Peptide
|
|
WO2005042575A2
(en)
|
2003-10-30 |
2005-05-12 |
Pharmexa A/S |
Method for down-regulation of vegf
|
|
JP2008044848A
(ja)
|
2004-11-30 |
2008-02-28 |
Univ Kurume |
Ｈｌａ−ａ２４拘束性腫瘍抗原ペプチド
|
|
US8252893B2
(en)
|
2005-01-31 |
2012-08-28 |
Board Of Trustees Of The University Of Arkansas |
CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
|
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
GB0603081D0
(en)
|
2006-02-15 |
2006-03-29 |
Dynal Biotech Asa Oslo |
Method
|
|
FR2898275B1
(fr)
|
2006-03-10 |
2012-12-14 |
Genethon |
Cellules t regulatrices cd4+cd25+specifiques pour la greffe de cellules hematopoietiques et la tolerance immunitaire
|
|
WO2007135684A2
(en)
|
2006-05-22 |
2007-11-29 |
Hadasit Medical Research Services & Development Limited |
Method of treatment of anti-cd4 autoimmunity
|
|
WO2008017517A1
(en)
|
2006-08-11 |
2008-02-14 |
Life Sciences Research Partners Vzw |
Immunogenic peptides and their use in immune disorders
|
|
EP2158211B1
(en)
|
2007-05-31 |
2016-08-10 |
Medigene AG |
Mutated structural protein of a parvovirus
|
|
WO2009042215A2
(en)
|
2007-09-27 |
2009-04-02 |
The Board Of Trustees Of The University Of Arkansas |
Inhibition of dendritic cell-driven regulatory t cell activation and potentiation of tumor antigen-specific t cell responses by interleukin-15 and map kinase inhibitor
|
|
EP2245059B1
(en)
|
2008-02-14 |
2017-09-20 |
Life Sciences Research Partners VZW |
Cd4+ t-cells with cytolytic properties
|
|
WO2009101206A2
(en)
*
|
2008-02-14 |
2009-08-20 |
Life Sciences Research Partners Vzw |
Strategies to prevent and/or treat immune responses to soluble allofactors
|
|
US20120009678A1
(en)
|
2008-02-14 |
2012-01-12 |
Jean-Marie Saint-Remy |
Immunotherapy targeting intracellular pathogens
|
|
WO2009101205A2
(en)
|
2008-02-14 |
2009-08-20 |
Life Sciences Research Partners Vzw |
Immunogenic control of tumours and tumour cells
|
|
WO2009100505A1
(en)
|
2008-02-14 |
2009-08-20 |
Life Sciences Research Partners Vzw |
Immunogenic peptides and their use in transplantati
|
|
WO2009101204A2
(en)
*
|
2008-02-14 |
2009-08-20 |
Life Sciences Research Partners Vzw |
Elimination of immune responses to viral vectors
|
|
WO2009106073A2
(en)
|
2008-02-28 |
2009-09-03 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
|
KR101022649B1
(ko)
|
2008-08-07 |
2011-03-22 |
삼성모바일디스플레이주식회사 |
헤테로고리 화합물 및 이를 이용한 유기 전계 발광 장치
|
|
WO2010037395A2
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
JP5942296B2
(ja)
|
2010-03-29 |
2016-06-29 |
サントル・ナショナル・ドゥ・ラ・ルシェルシュ・シャンティフィクＣｅｎｔｒｅ Ｎａｔｉｏｎａｌ Ｄｅ Ｌａ Ｒｅｃｈｅｒｃｈｅ Ｓｃｉｅｎｔｉｆｉｑｕｅ |
少なくとも１つのｃｘｘｃモチーフを含むポリペプチドと異種抗原とを含む医薬組成物、及びその使用
|
|
US10023847B2
(en)
|
2010-11-25 |
2018-07-17 |
Imnate Sarl |
Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
|
|
GB201201511D0
(en)
|
2012-01-30 |
2012-03-14 |
Univ Leuven Kath |
Modified epitopes for boosting CD4+ T-cell responses
|
|
CA2864432A1
(en)
|
2012-02-15 |
2013-08-22 |
Ecole Polytechnique Federale De Lausanne |
Erythrocyte-binding therapeutics
|
|
GB201309469D0
(en)
|
2013-05-28 |
2013-07-10 |
Imcyse Sa |
Detection of CD4+ T lymphocytes
|
|
GB201315946D0
(en)
|
2013-09-06 |
2013-10-23 |
Immune Targeting Systems Its Ltd |
Oncology vaccine
|
|
GB201319160D0
(en)
|
2013-10-30 |
2013-12-11 |
Imcyse Sa |
Methods for induction of antigen-specific regulatory t cells
|
|
GB201418433D0
(en)
|
2014-10-17 |
2014-12-03 |
Imcyse Sa |
Novel immunogenic peptides
|
|
US10729791B2
(en)
|
2015-05-18 |
2020-08-04 |
Imcyse Sa |
Animal models for evaluating pharmaceutical compounds
|
|
EP3352782B1
(en)
|
2015-09-25 |
2021-03-31 |
ImCyse SA |
Improved methods and compounds for eliminating immune responses to therapeutic agents
|
|
WO2017182528A1
(en)
|
2016-04-19 |
2017-10-26 |
Imcyse Sa |
Novel immunogenic cd1d binding peptides
|